1. Home
  2. BAFN vs KYNB Comparison

BAFN vs KYNB Comparison

Compare BAFN & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

HOLD

Current Price

$5.29

Market Cap

26.6M

Sector

Finance

ML Signal

HOLD

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$7.43

Market Cap

27.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BAFN
KYNB
Founded
1999
1993
Country
United States
United States
Employees
N/A
34
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.6M
27.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BAFN
KYNB
Price
$5.29
$7.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.0K
34.0K
Earning Date
04-30-2026
05-04-2026
Dividend Yield
1.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.15
Revenue Growth
N/A
N/A
52 Week Low
$4.26
$6.32
52 Week High
$15.45
$9.58

Technical Indicators

Market Signals
Indicator
BAFN
KYNB
Relative Strength Index (RSI) 50.42 69.70
Support Level $4.80 $6.66
Resistance Level $6.75 $7.95
Average True Range (ATR) 0.27 0.39
MACD 0.10 0.09
Stochastic Oscillator 87.61 75.32

Price Performance

Historical Comparison
BAFN
KYNB

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: